Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
35.23B | 32.65B | 32.27B | 27.16B | 27.71B | 26.25B | Gross Profit |
5.50B | 5.78B | 4.84B | 4.21B | 4.36B | 4.25B | EBIT |
2.78B | 2.95B | 2.18B | 1.73B | 1.90B | 1.80B | EBITDA |
3.05B | 2.96B | 2.57B | 2.11B | 2.26B | 2.00B | Net Income Common Stockholders |
1.99B | 1.79B | 1.59B | 1.28B | 1.37B | 1.18B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.24B | 7.99B | 8.76B | 8.35B | 8.24B | 8.61B | Total Assets |
27.19B | 30.29B | 33.22B | 29.12B | 27.19B | 26.05B | Total Debt |
1.08B | 566.15M | 1.02B | 1.01B | 1.08B | 1.05B | Net Debt |
-7.17B | -5.53B | -5.84B | -7.34B | -7.17B | -7.56B | Total Liabilities |
11.67B | 11.31B | 15.44B | 12.67B | 11.67B | 11.69B | Stockholders Equity |
15.52B | 18.98B | 17.78B | 16.44B | 15.52B | 14.36B |
Cash Flow | Free Cash Flow | ||||
0.00 | 695.13M | 1.88B | 1.16B | 676.98M | 1.42B | Operating Cash Flow |
0.00 | 1.13B | 1.98B | 1.32B | 965.19M | 1.58B | Investing Cash Flow |
0.00 | -839.99M | -1.09B | -802.87M | -1.10B | -735.67M | Financing Cash Flow |
0.00 | -1.11B | -486.81M | -446.03M | -263.17M | -197.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥13.53B | 7.58 | 4.74% | 1.16% | 12.22% | ||
76 Outperform | ¥12.91B | 7.40 | 4.75% | 33.76% | ― | ||
72 Outperform | ¥15.81B | 9.41 | 2.73% | -2.16% | -8.63% | ||
70 Neutral | ¥13.96B | 8.86 | 3.65% | 32.17% | 298.59% | ||
66 Neutral | $4.52B | 12.34 | 5.41% | 3.62% | 4.15% | -12.18% | |
62 Neutral | ¥14.77B | 11.57 | 4.59% | 1.27% | -5.17% | ||
61 Neutral | ¥13.46B | 81.16 | 2.71% | -2.45% | -71.57% |